PLXDC1 Antikörper (C-Term)
(4 Referenzen)Kurzübersicht für PLXDC1 Antikörper (C-Term) (ABIN1881662)
Target
Alle PLXDC1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Bindungsspezifität
- AA 466-494, C-Term
-
Aufreinigung
- This antibody is purified through a protein A column, followed by peptide affinity purification.
-
Immunogen
- This PLXDC1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 466-494 amino acids from the C-terminal region of human PLXDC1.
-
Isotyp
- Ig Fraction
-
-
anti-Plexin Domain Containing 1 (PLXDC1) (AA 313-421) antibody
PLXDC1 Reaktivität: Human WB, ELISA, RNAi Wirt: Maus Monoclonal 4B10 unconjugated
anti-Plexin Domain Containing 1 (PLXDC1) (AA 74-123) antibodyPLXDC1 Reaktivität: Human, Maus, Ratte, Hund, Pferd, Schwein WB, IHC, IHC (p) Wirt: Kaninchen Polyclonal unconjugated
anti-Plexin Domain Containing 1 (PLXDC1) (AA 1-500) antibodyPLXDC1 Reaktivität: Human WB, IP Wirt: Kaninchen Polyclonal unconjugated
anti-Plexin Domain Containing 1 (PLXDC1) (AA 1-500) antibodyPLXDC1 Reaktivität: Human WB Wirt: Maus Polyclonal unconjugated
anti-Plexin Domain Containing 1 (PLXDC1) (N-Term) antibodyPLXDC1 Reaktivität: Human WB Wirt: Kaninchen Polyclonal unconjugated
anti-Plexin Domain Containing 1 (PLXDC1) (N-Term) antibodyPLXDC1 Reaktivität: Human, Maus, Ratte, Hund, Pferd, Rind (Kuh), Meerschweinchen, Kaninchen WB Wirt: Kaninchen Polyclonal unconjugated
anti-Plexin Domain Containing 1 (PLXDC1) (C-Term) antibodyPLXDC1 Reaktivität: Human, Maus, Ratte WB, IHC (p), EIA Wirt: Kaninchen Polyclonal unconjugated
-
-
Applikationshinweise
- WB: 1:1000
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C
-
Haltbarkeit
- 6 months
-
-
-
: "Preferential expression of the secreted and membrane forms of tumor endothelial marker 7 transcripts in osteosarcoma." in: Anticancer research, Vol. 29, Issue 11, pp. 4317-22, (2009) (PubMed).
: "TEM7 (PLXDC1) in neovascular endothelial cells of fibrovascular membranes from patients with proliferative diabetic retinopathy." in: Investigative ophthalmology & visual science, Vol. 49, Issue 7, pp. 3151-7, (2008) (PubMed).
: "High expression of tumor endothelial marker 7 is associated with metastasis and poor survival of patients with osteogenic sarcoma." in: Gene, Vol. 399, Issue 2, pp. 137-43, (2007) (PubMed).
: "Identification of a binding partner for the endothelial cell surface proteins TEM7 and TEM7R." in: Cancer research, Vol. 64, Issue 23, pp. 8507-11, (2004) (PubMed).
-
: "Preferential expression of the secreted and membrane forms of tumor endothelial marker 7 transcripts in osteosarcoma." in: Anticancer research, Vol. 29, Issue 11, pp. 4317-22, (2009) (PubMed).
-
-
